Compare Stocks

→ Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APHA Aphria	$15.38	$15.48	$2.78 ▼ $32.29	$4.87B	2.67	21.83 million shs	N/A
CRON Cronos Group	$2.47 +4.7%	$2.33	$1.64 ▼ $2.99	$943.57M	1.17	2.93 million shs	2.33 million shs
STDAF STADA Arzneimittel Aktiengesellschaft	$110.42	$110.42	$75.15 ▼ $115.00	$6.88B	0.38	180 shs	N/A
TLRY Tilray	$1.84 +7.0%	$1.95	$1.50 ▼ $3.40	$1.42B	2.36	29.39 million shs	25.10 million shs
USNA USANA Health Sciences	$44.75 +1.2%	$47.51	$42.59 ▼ $69.60	$860.99M	0.91	80,236 shs	58,945 shs

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APHA Aphria	0.00%	0.00%	0.00%	0.00%	0.00%
CRON Cronos Group	-0.42%	-3.28%	-9.58%	+15.12%	+30.39%
STDAF STADA Arzneimittel Aktiengesellschaft	0.00%	0.00%	0.00%	0.00%	0.00%
TLRY Tilray	-0.58%	-3.37%	-25.54%	-15.27%	-25.22%
USNA USANA Health Sciences	+0.23%	+1.77%	-7.53%	-8.03%	-32.06%

Thousands of investors use this no cost solution | Do you? (Ad)

In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.

Simply tap here now to subscribe and start getting "Insider Financial Advantage"

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APHA Aphria	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	1.5659 of 5 stars	2.2	5.0	0.0	0.0	2.8	0.0	1.3
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	1.382 of 5 stars	3.1	2.0	0.0	0.0	2.3	0.0	1.3
USNA USANA Health Sciences	2.9797 of 5 stars	1.3	4.0	0.0	3.0	0.6	1.7	2.5

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APHA Aphria	N/A	N/A	N/A	N/A
CRON Cronos Group	2.33	Hold	$2.83	14.71% Upside
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A
TLRY Tilray	2.25	Hold	$2.71	47.19% Upside
USNA USANA Health Sciences	2.50	Moderate Buy	$48.00	7.26% Upside

Current Analyst Ratings

Latest APHA, CRON, TLRY, STDAF, and USNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/10/2024	TLRY Tilray	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$4.25 ➝ $4.00
4/10/2024	TLRY Tilray	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$2.25 ➝ $2.00
4/8/2024	CRON Cronos Group	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$2.00 ➝ $2.50
4/5/2024	TLRY Tilray	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral	$2.25 ➝ $2.75
2/22/2024	USNA USANA Health Sciences	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$53.00 ➝ $48.00

(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APHA Aphria	$405.96M	12.00	$0.09 per share	166.43	$4.80 per share	3.20
CRON Cronos Group	$87.24M	10.82	N/A	N/A	$2.87 per share	0.86
STDAF STADA Arzneimittel Aktiengesellschaft	$3.84B	1.79	$11.12 per share	9.93	$23.11 per share	4.78
TLRY Tilray	$627.12M	2.27	N/A	N/A	$5.07 per share	0.36
USNA USANA Health Sciences	$921.01M	0.93	$4.46 per share	10.03	$25.99 per share	1.72

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APHA Aphria	-$63.21M	-$0.06	N/A	219.71	N/A	-36.10%	-2.30%	-1.66%	N/A
CRON Cronos Group	-$73.96M	-$0.19	N/A	82.33	N/A	-84.15%	-3.99%	-3.87%	5/14/2024 (Estimated)
STDAF STADA Arzneimittel Aktiengesellschaft	$292.15M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	-$1.45B	-$0.44	N/A	N/A	N/A	-43.98%	-2.68%	-2.09%	7/24/2024 (Estimated)
USNA USANA Health Sciences	$63.79M	$3.30	13.56	14.30	1.35	6.93%	13.49%	10.45%	4/30/2024 (Confirmed)

Latest APHA, CRON, TLRY, STDAF, and USNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/30/2024	N/A	USNA USANA Health Sciences	$0.69	N/A	-$0.69	N/A	N/A	N/A
2/29/2024	Q4 2023	CRON Cronos Group	N/A	-$0.05	-$0.05	$0.02	$25.15 million	$23.92 million
2/6/2024	Q4 2023	USNA USANA Health Sciences	$0.52	$0.87	+$0.35	$0.87	$206.70 million	$221.08 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APHA Aphria	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	N/A	N/A	N/A	N/A	N/A
USNA USANA Health Sciences	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APHA Aphria	0.25	2.36	1.17
CRON Cronos Group	N/A	22.54	21.81
STDAF STADA Arzneimittel Aktiengesellschaft	2.23	1.54	0.99
TLRY Tilray	0.11	1.92	1.18
USNA USANA Health Sciences	N/A	3.52	3.00

Ownership

Institutional Ownership

Company	Institutional Ownership
APHA Aphria	10.30%
CRON Cronos Group	8.71%
STDAF STADA Arzneimittel Aktiengesellschaft	N/A
TLRY Tilray	9.35%
USNA USANA Health Sciences	54.25%

Insider Ownership

Company	Insider Ownership
APHA Aphria	N/A
CRON Cronos Group	1.96%
STDAF STADA Arzneimittel Aktiengesellschaft	N/A
TLRY Tilray	0.68%
USNA USANA Health Sciences	0.33%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
APHA Aphria	1,200	316.80 million	N/A	Optionable
CRON Cronos Group	356	382.01 million	374.52 million	Optionable
STDAF STADA Arzneimittel Aktiengesellschaft	12,500	62.34 million	N/A	Not Optionable
TLRY Tilray	1,600	774.03 million	768.77 million	Optionable
USNA USANA Health Sciences	1,800	19.24 million	19.18 million	Optionable

APHA, CRON, TLRY, STDAF, and USNA Headlines

Source	Headline
	USANA Health Sciences (USNA) Set to Announce Earnings on Tuesday americanbankingnews.com - April 23 at 4:54 AM
	USANA Health Sciences (NYSE:USNA) Reaches New 1-Year Low at $43.83 americanbankingnews.com - April 14 at 5:50 AM
	USANA Health Sciences (NYSE:USNA) Sets New 12-Month Low at $43.83 marketbeat.com - April 12 at 3:59 PM
	USANA Schedules First Quarter 2024 Earnings Release and Conference Call businesswire.com - April 10 at 4:15 PM
	USANA Cements Itself as a Premier Cellular Nutrition Company in South Korea prnewswire.com - April 9 at 9:08 AM
	USANA Health Sciences, Inc. (NYSE:USNA) has caught the attention of institutional investors who hold a sizeable 49% stake finance.yahoo.com - April 8 at 4:46 PM
	Vanguard Group Inc. Has $91.85 Million Stock Position in USANA Health Sciences, Inc. (NYSE:USNA) marketbeat.com - April 6 at 4:14 AM
	Kevin Guest Says This Spring Cultivate a Growth Mindset: The Essential Soft Skill for Business Success in 2024 finance.yahoo.com - April 2 at 8:04 AM
	USANA Health Sciences, Inc. (NYSE:USNA) Stock Holdings Increased by Pacer Advisors Inc. marketbeat.com - March 27 at 6:12 AM
	Some Investors May Be Worried About USANA Health Sciences' (NYSE:USNA) Returns On Capital finance.yahoo.com - March 25 at 1:14 PM
	USNA Apr 2024 45.000 put finance.yahoo.com - March 16 at 3:38 PM
	USANA Health Sciences, Inc. (NYSE:USNA) COO Walter Noot Sells 5,240 Shares insidertrades.com - March 12 at 5:01 AM
	Usana Health Sciences Inc (USNA) Executive Chairman of the Board Kevin Guest Sells 11,011 Shares finance.yahoo.com - March 11 at 9:34 PM
	Usana Health Sciences Inc (USNA) Chief Scientific Officer Robert Sinnott Sells Company Shares finance.yahoo.com - March 6 at 6:45 PM
	Usana Health Sciences Inc's Chief Legal Officer Joshua Foukas Sells Company Shares finance.yahoo.com - March 4 at 5:35 PM
	Kevin Guest Says Leap Forward on Leap Day prnewswire.com - February 28 at 7:03 AM
	USANA Sustainability and DEI Executive Director Awarded in Utah prnewswire.com - February 22 at 9:47 AM
	Jim Simons Adjusts Position in Usana Health Sciences Inc finance.yahoo.com - February 14 at 4:28 AM
	USANA Health Sciences Full Year 2023 Earnings: EPS Beats Expectations finance.yahoo.com - February 8 at 9:57 AM
	USANA Health Sciences, Inc. (NYSE:USNA) Q4 2023 Earnings Call Transcript finance.yahoo.com - February 8 at 9:57 AM
	USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates finance.yahoo.com - February 7 at 12:08 AM
	Usana Health Sciences Inc (USNA) Reports Mixed Fiscal Year 2023 Results finance.yahoo.com - February 6 at 7:08 PM
	USANA Health Sciences Q4 Income Climbs, Beats estimates markets.businessinsider.com - February 6 at 7:08 PM
	USANA (NYSE:USNA) Q4 Sales Beat Estimates finance.yahoo.com - February 6 at 7:08 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Micron Technology Results Proves AI is Driving Storage Demand
March 26, 2024 7:35 AM
View Micron Technology Results Proves AI is Driving Storage Demand
Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
April 10, 2024 10:42 AM
View Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
Cannabis: One Stock to Play the Movement
April 8, 2024 8:38 AM
View Cannabis: One Stock to Play the Movement
Tencent Is Looking to Fill Nvidia’s Gap in China’s Chip Market
March 25, 2024 4:41 PM
View Tencent Is Looking to Fill Nvidia’s Gap in China’s Chip Market
Tilray’s Q3 Earnings Reveal Growth Despite Challenges
April 10, 2024 7:20 AM
View Tilray’s Q3 Earnings Reveal Growth Despite Challenges

All Headlines

Company Descriptions

Aphria

NASDAQ:APHA

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Cronos Group

NASDAQ:CRON

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

STADA Arzneimittel Aktiengesellschaft

OTCMKTS:STDAF

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

Tilray

NASDAQ:TLRY

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.

USANA Health Sciences

NYSE:USNA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial